Market regulation · 09/05/1994Updated: 10/16/2026 · 1 min read
Cumulative List of Orphan-Drug and Biological Designations
Summary
The Food and Drug Administration (FDA) has announced the availability of a cumulative list of designated orphan drugs and biologics as of December 31, 1993, updating previous lists monthly.
Original source language: Federal Register — Federal Trade CommissionOpen original release →